$ORCL

Forget Oracle's Stock Price Swings. Its Backlog

Oracle (NYSE: ORCL) reported a $664B backlog, with $300B from OpenAI contracts. Despite a 28% YTD stock decline, the company expects 34% revenue growth and 19% earnings growth. The backlog is 9.2x its trailing 12-month sales, indicating strong future demand for AI cloud services, though OpenAI concentration poses risks.

Original reporting
Published Sep 17, 2026, 4:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 4:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Forget Oracle's Stock Price Swings. Its Backlog — source image
Decision brief

The 30-second read

$ORCLBullishMed
01

Why it matters

The disclosed backlog and guidance could reprice Oracle's valuation, especially for investors focused on AI exposure.

02

Market read

Oracle's new guidance and massive AI‑related backlog may trigger a reassessment of its growth prospects across the tech sector.

03

What to watch

Potential margin pressure from rapid cloud capacity expansion and competitive pressure from other AI cloud providers.

Relevance 8/10Novelty 8/10Timing: latest quarter guidance release

Background

Oracle's cloud business is positioning itself as a key AI infrastructure provider, leveraging a sizable backlog to drive future growth.

Company-level read

Ticker impact

$ORCLBullishHigh confidence
Context

Oracle disclosed a remaining performance obligation of $664 billion, with $300 billion tied to OpenAI, and guided revenue growth of ~34% and earnings growth of ~19% for the year.

Expected impact

Potential upside of 15‑20% if guidance is fully priced in and OpenAI spending remains on track.

Evidence & confidence

Backlog size relative to sales (9.2x) and high‑growth guidance indicate strong future revenue visibility, outweighing concentration risk.

Market effects

Highlights growing demand for AI‑focused cloud infrastructure, benefiting the broader enterprise‑cloud sector.

U.S. tech stocks may see a lift as investors reassess AI infrastructure exposure.

OpenAI's large contract underscores the global race for AI compute capacity.

Counterpoint

The concentration of $300 billion in a single customer could expose Oracle to downside if OpenAI curtails spending.

Key entities

  • Oracle

    U.S. enterprise‑software and cloud services provider.

  • OpenAI

    AI research lab and provider of ChatGPT, source of a large portion of Oracle's backlog.

Related articles

$ORCLHighAI 8/10

Oracle’s 2026 Cratering: This Pro Is Sure It Will Nearly Triple in the Next 12 Months

Oracle (ORCL) shares fell 11.39% in a week and 25.8% year-to-date despite Q1 FY27 earnings beating estimates. Revenue grew 29.61% to $19.345 billion, cloud infrastructure revenue surged 121%, and remaining performance obligations reached $664 billion. Concerns include high capital expenditure and negative free cash flow. Analysts maintain an average price target of $239, with some targeting $400. Management raised FY27 revenue guidance to at least $90 billion and $8.10 in non-GAAP EPS.

$IBMMedAI 8/10

Quantum Computing News: IBM Gets $1B Award as IONQ Taps Nvidia AI

IBM's Anderon received a $1B U.S. award for quantum wafer R&D, with IBM investing another $1B. IQM Quantum Computers signed a deal for its first South American quantum computer. IonQ and Nvidia tested generative AI for quantum optimization. D-Wave plans to showcase its annealing and gate-model systems. Oracle added post-quantum cryptography to Java 27.

$ORCLHighAI 8/10

Monday's Stock to Watch: Oracle, Blue Owl, and Apollo

Oracle (ORCL) announced an additional $700M restructuring charge due to layoffs, potentially impacting its stock. Blue Owl (OWL) saw a 10.81% drop in stock value, closing at $10.56, amid loan write-down concerns. Apollo (APO) is in talks to acquire J&J’s (JNJ) orthopedics unit, with mixed performance in the medical devices sector.

$ORCLHighAI 8/10

Larry Ellison cancels plan to sell up to $7.5bn of Oracle stock

Larry Ellison, Oracle's Executive Chair, canceled a plan to sell up to $7.5bn of Oracle (NYSE: ORCL) stock, according to the company. The plan, covering 50 million shares, was announced on 22 June 2026 and canceled on 12 September 2026. Oracle reported Q1 2026 revenue of $19.345bn, up from $14.926bn a year earlier, with net income rising to $4.76bn from $2.927bn. The company's cloud infrastructure unit grew 121% year-on-year to $7.4bn.